(Zhou et al. 2022) These findings suggest that TMAO may mitigate liver fibrosis through attenuation of ATP1B1 expression and consequent improvement of endothelial integrity, a potential mechanism that highlights the organ-specific relationship between TMAO and fibrosis. The gene discussed is ATP1B1; the disease is Hepatic fibrosis.